Convention Invisibility Teaches A Crucial Health Policy Lesson

By MICHAEL MILLENSON It’s close to an iron rule: Politics drives policy. In that context, the health policy issues that were largely invisible at the Republican and Democratic conventions taught a crucial political lesson. Start with access. According to KFF (formerly the Kaiser Family Foundation), more than 25 million Americans have been disenrolled from Medicaid as of…

Read More

ICE Arrests Are Separating Families. Here’s How To Plan Ahead.

President Donald Trump’s immigration crackdown has parents who lack legal residency worried about the welfare of children left behind. Some jurisdictions are taking action. Maryland, Virginia, and Washington, D.C., allow families to name temporary guardians if a parent is detained or deported. KFF Health News correspondent Jazmin Orozco Rodriguez appeared on WAMU’s May 13 Health…

Read More

Operational efficiencies of using one vs multiple bispecific antibodies for diffuse large B-cell lymphoma and follicular lymphoma in the US

That is the title of a new paper published in Future Oncology with co-authors Tara Graff,Savreet Bains Chawla,Monika Jun,Nicole Heaps,Abualbishr Alshreef,David Tybor,Donald C. Moore,Nadine Zawadzki, and Kathryn Spurrier. The abstract is below: Aim To quantify the time- and cost-savings to US oncology practices from using a single bispecific antibody (bsAb) for both relapsed/refractory (R/R) diffuse…

Read More

Under FDA Clinical Hold, Aardvark Therapeutics Seeks Path Forward for Metabolic Drug

The full FDA clinical hold formally halts all tests of Aardvark Therapeutics’ drug for Prader-Willi syndrome, a rare inherited metabolic disorder that leads to excessive eating. Earlier this year, Aardvark voluntarily paused all tests of its small molecule after a cardiovascular problem emerged in a healthy volunteer. The post Under FDA Clinical Hold, Aardvark Therapeutics…

Read More